AGC1 deficiency associated with global cerebral hypomyelination.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19641205.
- Also identified by DOI 10.1056/NEJMoa0900591.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The mitochondrial aspartate-glutamate carrier isoform 1 (AGC1), specific to neurons and muscle, supplies aspartate to the cytosol and, as a component of the malate-aspartate shuttle, enables mitochondrial oxidation of cytosolic NADH, thought to be important in providing energy for neurons in the central nervous system. We describe AGC1 deficiency, a novel syndrome characterized by arrested psychomotor development, hypotonia, and seizures in a child with a homozygous missense mutation in the solute carrier family 25, member 12, gene SLC25A12, which encodes the AGC1 protein. Functional analysis of the mutant AGC1 protein showed abolished activity. The child had global hypomyelination in the cerebral hemispheres, suggesting that impaired efflux of aspartate from neuronal mitochondria prevents normal myelin formation.
Medical subject headings
- Amino Acid Transport Systems, Acidic
- Antiporters
- Cerebrum
- Epilepsy
- Hereditary Central Nervous System Demyelinating Diseases
- Mitochondrial Membrane Transport Proteins
- Mutation, Missense
- Psychomotor Disorders